These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38433073)

  • 1. The effect of erythropoiesis-stimulating agents on systolic and diastolic blood pressure in hemodialysis patients: A systematic review and meta-analysis of clinical trials.
    Karimi Z; Raeisi Shahraki H; Mohammadian-Hafshejani A
    Med Clin (Barc); 2024 May; 162(10):e43-e51. PubMed ID: 38433073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating the relationship between erythropoiesis-stimulating agents and mortality in hemodialysis patients: A systematic review and meta-analysis.
    Karimi Z; Raeisi Shahraki H; Mohammadian-Hafshejani A
    PLoS One; 2023; 18(11):e0293980. PubMed ID: 37943776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality risk of darbepoetin alfa versus epoetin alfa in patients with CKD: systematic review and meta-analysis.
    Wilhelm-Leen ER; Winkelmayer WC
    Am J Kidney Dis; 2015 Jul; 66(1):69-74. PubMed ID: 25636816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of resveratrol on blood pressure: a meta-analysis of randomized controlled trials.
    Liu Y; Ma W; Zhang P; He S; Huang D
    Clin Nutr; 2015 Feb; 34(1):27-34. PubMed ID: 24731650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of proanthocyanidins on blood pressure: A systematic review and meta-analysis of randomized controlled trials.
    Ren J; An J; Chen M; Yang H; Ma Y
    Pharmacol Res; 2021 Mar; 165():105329. PubMed ID: 33465473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effectiveness and cost-effectiveness of erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating cancer treatment-induced anaemia (including review of technology appraisal no. 142): a systematic review and economic model.
    Crathorne L; Huxley N; Haasova M; Snowsill T; Jones-Hughes T; Hoyle M; Briscoe S; Coelho H; Long L; Medina-Lara A; Mujica-Mota R; Napier M; Hyde C
    Health Technol Assess; 2016 Feb; 20(13):1-588, v-vi. PubMed ID: 26907163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis.
    Palmer SC; Saglimbene V; Mavridis D; Salanti G; Craig JC; Tonelli M; Wiebe N; Strippoli GF
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010590. PubMed ID: 25486075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of malnutrition-inflammation complex and responsiveness to erythropoiesis-stimulating agents in long-term hemodialysis patients.
    Rattanasompattikul M; Molnar MZ; Zaritsky JJ; Hatamizadeh P; Jing J; Norris KC; Kovesdy CP; Kalantar-Zadeh K
    Nephrol Dial Transplant; 2013 Jul; 28(7):1936-45. PubMed ID: 23045431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood pressure increase after erythropoietin injection in hemodialysis and predialysis patients.
    Noshad H
    Iran J Kidney Dis; 2013 May; 7(3):220-5. PubMed ID: 23689155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Erythropoietin-Stimulating Agents (ESA) in Patients With End-Stage Renal Failure Decided to Forego Dialysis: Palliative Perspective.
    Cheng HW; Chan KY; Lau HT; Man CW; Cheng SC; Lam C
    Am J Hosp Palliat Care; 2017 May; 34(4):380-384. PubMed ID: 26718957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Opatija study: observation of hemodialysis patients and titration of CERA dose just switched from another erythropoiesis stimulating agent].
    Jelić I; Lovcić V; Kurtović I; Josipović M; Havranek Z; Kostić L; Racki S
    Acta Med Croatica; 2012 Jul; 66(3):157-64. PubMed ID: 23441529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis.
    Chung EY; Palmer SC; Saglimbene VM; Craig JC; Tonelli M; Strippoli GF
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD010590. PubMed ID: 36791280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ambulatory blood pressure monitoring and peri-hemodialysis blood pressures in a southeast US hemodialysis unit.
    Fülöp T; Schmidt DW; Cosmin A; Islam N; Wells C; Lengvárszky Z; Bilbrew DM; Zsom L
    Clin Nephrol; 2012 May; 77(5):383-91. PubMed ID: 22551884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of Erythropoietin-Stimulating Agents on Health-Related Quality of Life in Anemia of Chronic Kidney Disease: A Systematic Review and Meta-analysis.
    Collister D; Komenda P; Hiebert B; Gunasekara R; Xu Y; Eng F; Lerner B; Macdonald K; Rigatto C; Tangri N
    Ann Intern Med; 2016 Apr; 164(7):472-8. PubMed ID: 26881842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the SpaceLabs 90207 ambulatory blood pressure device for hemodialysis patients.
    Peixoto AJ; Gray TA; Crowley ST
    Blood Press Monit; 1999 Oct; 4(5):217-21. PubMed ID: 10547641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoiesis-stimulating agents for anemia in rheumatoid arthritis.
    Martí-Carvajal AJ; Agreda-Pérez LH; Solà I; Simancas-Racines D
    Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD000332. PubMed ID: 23450527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation, high ferritin, and erythropoietin resistance in indigenous maintenance hemodialysis patients from the Top End of Northern Australia.
    Majoni SW; Ellis JA; Hall H; Abeyaratne A; Lawton PD
    Hemodial Int; 2014 Oct; 18(4):740-50. PubMed ID: 24766376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten years of meta-analyses on erythropoiesis-stimulating agents in cancer patients.
    Tonia T; Bohlius J
    Cancer Treat Res; 2011; 157():217-38. PubMed ID: 21052959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.